Continuous Effector CD8(+) T Cell Production in a Controlled Persistent Infection Is Sustained by a Proliferative Intermediate Population.

Continuous Effector CD8(+) T Cell Production in a Controlled Persistent Infection Is Sustained by a Proliferative Intermediate Population.

Item
http://www.wikidata.org/entity/Q37116126
CD8+ T Lymphocyte Self-Renewal during Effector Cell Determination.Cytomegalovirus vector expressing RAE-1γ induces enhanced anti-tumor capacity of murine CD8+ T cells.MHC I presentation of Toxoplasma gondii immunodominant antigen does not require Sec22b and is regulated by antigen orientation at the vacuole membrane.Th1 Differentiation Drives the Accumulation of Intravascular, Non-protective CD4 T Cells during Tuberculosis.Reducing persistent polyomavirus infection increases functionality of virus-specific memory CD8 T cells.Brains and Brawn: Toxoplasma Infections of the Central Nervous System and Skeletal Muscle.Self-renewal capacity of semi-differentiated CD8+ T cells sustains long-term protective responses in chronic persistent infection.CD103+ CD8 T Cells in the Toxoplasma-Infected Brain Exhibit a Tissue-Resident Memory Transcriptional Profile.Deep immune profiling by mass cytometry links human T and NK cell differentiation and cytotoxic molecule expression patterns.Adenoviral vaccine induction of CD8+ T cell memory inflation: Impact of co-infection and infection order.Cyclophosphamide treatment regulates the balance of functional/exhausted tumor-specific CD8+ T cells.T Cell Receptor-Major Histocompatibility Complex Interaction Strength Defines Trafficking and CD103+ Memory Status of CD8 T Cells in the Brain.PD-L1, TIM-3, and CTLA-4 blockade fail to promote resistance to secondary infection with virulent strains of
P2860

Continuous Effector CD8(+) T Cell Production in a Controlled Persistent Infection Is Sustained by a Proliferative Intermediate Population.

Item
http://www.wikidata.org/entity/Q37116126
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Continuous Effector CD8
@nl
Continuous Effector CD8(+) T C ...... ative Intermediate Population.
@en
Continuous Effector CD8(+) T C ...... ative Intermediate Population.
@en-gb
type
label
Continuous Effector CD8
@nl
Continuous Effector CD8(+) T C ...... ative Intermediate Population.
@en
Continuous Effector CD8(+) T C ...... ative Intermediate Population.
@en-gb
prefLabel
Continuous Effector CD8
@nl
Continuous Effector CD8(+) T C ...... ative Intermediate Population.
@en
Continuous Effector CD8(+) T C ...... ative Intermediate Population.
@en-gb
P1154
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P5530
P577
P6179
P6366
P698
P932
P953
P356
P6366
P1154
P1433
P1476
Continuous Effector CD8(+) T C ...... ative Intermediate Population.
@en
P2093
P2860
P304
P31
P356
10.1016/J.IMMUNI.2016.06.013
P407
P433
P478
P50
P5530
P577
P6179
P6366
P698
P932
P953